Prodrug design : perspectives, approaches and applications in medicinal chemistry / (Record no. 247115)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 06014cam a2200577Ii 4500 |
001 - CONTROL NUMBER | |
control field | ocn913829107 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20190328114812.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 150715s2015 ne ob 000 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | N$T |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | N$T |
Modifying agency | OPELS |
-- | N$T |
-- | EBLCP |
-- | YDXCP |
-- | IDEBK |
-- | CDX |
-- | DEBSZ |
-- | OCLCF |
-- | OCLCQ |
-- | CASUM |
-- | OCLCO |
-- | MERER |
-- | OCLCO |
-- | OCLCQ |
-- | OCLCA |
-- | WRM |
-- | U3W |
-- | OCLCO |
-- | D6H |
-- | OCLCQ |
-- | WYU |
-- | OCLCA |
-- | CUY |
-- | LOA |
-- | ZCU |
-- | MERUC |
-- | OCLCO |
-- | ICG |
-- | USU |
-- | OCLCO |
-- | K6U |
-- | COCUF |
-- | OCLCQ |
-- | DKC |
-- | OCLCO |
019 ## - | |
-- | 914148150 |
-- | 1066572097 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780128035573 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0128035579 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780128035191 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)913829107 |
Canceled/invalid control number | (OCoLC)914148150 |
-- | (OCoLC)1066572097 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RS403 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | 2015 J-592 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | QV 785 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED |
Subject category code subdivision | 071000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.1/9 |
Edition number | 23 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Redasani, Vivekkumar K., |
Relator term | author. |
245 10 - TITLE STATEMENT | |
Title | Prodrug design : perspectives, approaches and applications in medicinal chemistry / |
Medium | [electronic resource] |
Statement of responsibility, etc. | Vivekkumar K. Redasani, Sanjay B. Bari. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | [Amsterdam] : |
Name of producer, publisher, distributor, manufacturer | Academic Press is an imprint of Elsevier, |
Date of production, publication, distribution, manufacture, or copyright notice | 2015. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
588 0# - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Online resource; title from PDF title page (ScienceDirect, viewed July 16, 2015). |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Front Cover; Prodrug Design; Copyright Page; Dedication; Contents; Preface; 1 Introduction; 1.1 Background; 1.2 Drug Development; 1.3 The Drug Discovery Process; 1.3.1 Goal of Drug Discovery; 1.3.2 Constraints in Drug Discovery; 1.4 Current Scenario in Prodrug Research; 1.5 Need of the Study; References; 2 Concept of Prodrug; 2.1 Concept of Prodrug; 2.2 Undesirable Properties Associated with Drug Molecules; 2.3 Prodrug Design: Past to Present; 2.4 Definitions of Prodrug; 2.5 Rationale for the Use of Prodrugs; 2.6 Targeted Prodrug Design; 2.7 Double Prodrug Concept; 2.8 Steps in Prodrug Design. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 2.8.1 Hard Drugs2.8.2 Soft Drugs; 2.9 Objectives in Prodrug Research; 2.9.1 Pharmaceutical Objectives; 2.9.2 Pharmacokinetic Objectives; 2.9.3 Pharmacodynamic Objectives; 2.10 Evaluation of Prodrugs; 2.10.1 Physiochemical Parameters; 2.10.2 Pharmacokinetics Profile; 2.10.3 Pharmacodynamics; References; 3 Types of Prodrugs; 3.1 Classification of Prodrugs; 3.1.1 Research-Related Criteria; 3.1.2 Chemical Criteria; 3.1.2.1 Carrier-Linked Prodrug; 3.1.2.2 Mutual Prodrug; 3.1.2.3 Bioprecursor Prodrug; 3.1.2.3.1 Oxidative Bioactivations; 3.1.2.3.2 Reductive Bioactivations; 3.1.2.4 Polymeric Prodrug. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 3.1.2.5 Tripartate Prodrug3.2 Criteria for Prodrug; 3.3 Classifying Prodrugs; 3.4 Challenges and Limitations in Prodrug Design; References; 4 Approaches for Prodrugs; 4.1 Promoiety; 4.2 Functional Groups Compliant for Design of Prodrug; 4.3 Bioreversible Derivatives for Various Functional Groups; 4.4 Phosphate Esters as Prodrugs of Hydroxyl or Amine Functionalities; 4.5 Amides as Prodrugs of Carboxylic Acids and Amines; 4.6 Prodrug for Amides, Imides, and Other Acidic Compounds; 4.6.1 N-Mannich Bases and Acyloxy Derivatives; 4.6.2 N-Acyl Derivatives; 4.6.3 N-Hydroxy Methyl Derivatives. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 4.7 Prodrugs for Amines4.7.1 N-(Acyloxy Alkoxy Carbonyl) Derivatives and Amide Derivatives; 4.7.2 Oxazolidines; 4.8 Prodrugs with Carbonyl groups; 4.8.1 Thiazolidines; 4.8.2 Enol Esters; 4.9 Types of Promoieties Used in Designing of Prodrugs; 4.9.1 Amino Acids; 4.9.2 Polysaccharides; 4.9.3 Alcohols; 4.9.4 Phytophenols; 4.9.5 Amines; 4.9.6 Polymers; 4.9.6.1 Requirements for Selecting Polymers as Candidate Drug Carriers; 4.9.6.2 Classification of Polymers Used for Bioconjugation; 4.10 Coupling of Drug and Polymer Through Spacers; References; 5 Applications; 5.1 Applications of Prodrug Designing. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 5.1.1 Masking Taste and Odor5.1.2 Minimizing Pain at Injection Site; 5.1.3 Alteration of Drug Solubility; 5.1.4 Enhancement of Chemical Stability; 5.1.5 Prodrugs to Overcome Absorption Problems; 5.1.5.1 Enhancement of Oral Absorption; 5.1.5.2 Enhancement of Ophthalmic Absorption; 5.1.5.3 Enhancement of Percutaneous Absorption; 5.1.6 Prevention of Presystemic Metabolism; 5.1.7 Longer Duration of Action; 5.1.8 To Diminish Local and Systemic Toxicity of Drugs/Reduction of GI Irritability; 5.1.9 Site-Specific Drug Delivery; 5.1.10 Prodrug for Slow and Prolonged Release (Sustained Drug Action). |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Prodrug Design: Perspectives, Approaches and Applications in Medicinal Chemistry provides a focused overview of this critical area of drug discovery, as that continuous process strives not only to discover new drug compounds but also to modify the existing ones. This valuable primer supports this mission of drug development and its goal of reducing undesired effects and improving therapeutic effectiveness of drug compounds. Providing a unique compilation of data, insightful case studies, and review of existing literature in the area, the book will promote innovation in medicinal and pharmaceu. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmaceutical chemistry. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Design. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | MEDICAL |
General subdivision | Pharmacology. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs |
General subdivision | Design. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst00898790 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmaceutical chemistry. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst01060115 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Prodrugs. |
Authority record control number | (DNLM)D011355 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug Design. |
Authority record control number | (DNLM)D015195 |
655 #7 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
Source of term | lcgft |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bari, Sanjay B., |
Relator term | author. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Redasani, Vivekkumar K. |
Title | Prodrug Design : Perspectives, Approaches and Applications in Medicinal Chemistry. |
Place, publisher, and date of publication | Burlington : Elsevier Science, �2015 |
International Standard Book Number | 9780128035191 |
Record control number | (DLC) 2017287392 |
-- | (OCoLC)909329794 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | ScienceDirect |
Uniform Resource Identifier | http://www.sciencedirect.com/science/book/9780128035191 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | ScienceDirect |
Uniform Resource Identifier | https://www.sciencedirect.com/science/book/9780128035191 |
No items available.